Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT07396207 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

Gamified Metaverse Education for Ventrogluteal IM Injection (G-META-IM)

Study acronym: G-META-IM
StatusNot Yet Recruiting
PhaseNot applicable
Started
View on ClinicalTrials.gov ↗
Record status
This record was last updated February 9, 2026 (before its estimated May 2026 completion). Its status may not reflect the trial's current state.

Record History

  1. Minor Study First Submitted
This study aims to examine the effect of a gamified, metaverse-based education program on nursing students' knowledge and attitudes regarding ventrogluteal intramuscular injection. Intramuscular injection is a commonly used nursing skill that requires accurate anatomical knowledge and correct technique to ensure patient safety. The ventrogluteal site is considered a safe injection site; however, nursing students often report limited knowledge and confidence in its use. In this study, nursing students will be assigned to either an intervention group or a control group. The intervention group will receive a gamified metaverse-based educational program designed to teach ventrogluteal site identification using the V method and the correct steps of intramuscular injection. The control group will receive traditional education using standard teaching methods. Data will be collected before and after the educational intervention using a knowledge test and a learning attitude scale. The results of this study are expected to provide evidence on the effectiveness of metaverse-based and gamified education approaches in nursing education and to support the development of safe and innovative learning environments for nursing students.
Trial Details
NCT Number NCT07396207
Lead Sponsor Suleyman Demirel University
Conditions
(from sponsor)
Nursing Education, Intramuscular Injection, Metaverse
Enrollment 60 participants
Start Date
Primary Completion (estimated)
Study Completion (estimated)
Updated on ClinicalTrials.gov